EcoDrugPlus

Histamine Receptor H1

Ensembl ID : ENSSMAG00000014111
Gene Symbol: HRH1
3 Cross references
186 Possible Orthologues:

Histamine Receptor H2b

Ensembl ID : ENSSMAG00000019007
Gene Symbol: HRH2B
2 Cross references
182 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSSMAG00000020613
Gene Symbol: HDAC1
1 Cross references
71 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSSMAG00000007246
Gene Symbol: HDAC10
1 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSSMAG00000023297
Gene Symbol: HDAC11
3 Cross references
200 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSSMAG00000004037
Gene Symbol: HDAC4
1 Cross references
202 Possible Orthologues:

Histone Deacetylase 4-Like

Ensembl ID : ENSSMAG00000014149
Gene Symbol: LOC118320143
2 Cross references
196 Possible Orthologues:

Histone Deacetylase 7-Like

Ensembl ID : ENSSMAG00000007505
Gene Symbol: LOC118308730
2 Cross references
195 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSSMAG00000002387
Gene Symbol: HDAC8
3 Cross references
205 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSSMAG00000008390
Gene Symbol: HCN4
3 Cross references
221 Possible Orthologues:

Hypocretin (Orexin) Receptor 2

Ensembl ID : ENSSMAG00000005815
Gene Symbol: HCRTR2
3 Cross references
203 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSSMAG00000006624
Gene Symbol: IKBKB
3 Cross references
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).